SCHEMBL2357484

SCHEMBL2357484

[CH](c1ccccc1)c1ccc([CH]c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
MAOB P27338 2/20 0.50
TSHR P16473 1/20 0.50
CYP2A6 P11509 1/20 0.50
NFE2L2 Q16236 1/20 0.48
CYP19A1 P11511 1/20 0.48
MAOA P21397 1/20 0.48
LMNA P02545 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
RELA Q04206 2/20 0.42
TRPA1 O75762 2/20 0.42
ALOX5 P09917 1/20 0.41
MAPK1 P28482 1/20 0.41
HDAC3 O15379 1/20 0.39
TNKS O95271 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1302 0.96 ALDH1A1 (0.53) ALDH1A1MAOBTSHRCYP2A6NFE2L2
SCHEMBL28995582 0.92 ALDH1A1 (0.50) ALDH1A1MAOBTSHRCYP2A6NFE2L2
SCHEMBL29124096 0.92 ALDH1A1 (0.50) ALDH1A1MAOBTSHRCYP2A6NFE2L2
SCHEMBL22711559 0.92 ALDH1A1 (0.50) ALDH1A1MAOBTSHRCYP2A6NFE2L2
SCHEMBL291507 0.87 ALDH1A1 (0.53) ALDH1A1MAOBTSHRCYP2A6NFE2L2
SCHEMBL29111027 0.86 ALDH1A1 (0.53) ALDH1A1MAOBTSHRCYP2A6NFE2L2
SCHEMBL439444 0.85 G6PD (0.54) MAOBTSHRCYP2A6NFE2L2LMNA
SCHEMBL5946614 0.85 ESR1 (0.54) ALDH1A1MAOBCYP19A1MAOALMNA
SCHEMBL7441695 0.85 G6PD (0.54) ALDH1A1MAOBTSHRCYP2A6NFE2L2
SCHEMBL5253400 0.85 MAOA (0.71) ALDH1A1MAOBTSHRCYP19A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994372-B2 Parylene variants and methods of synthesis and use SPECIALTY COATING SYSTEMS, INC. (US) 2011-08-09 US disclosed
US-20090186998-A1 PARYLENE VARIANTS AND METHODS OF SYNTHESIS AND USE SPECIALTY COATING SYSTEMS, INC. (US) 2009-07-23 US disclosed
US-7462750-B2 Parylene variants and methods of synthesis and use SPECIALTY COATING SYSTEMS, INC. (US) 2008-12-09 US disclosed
EP-1943200-A2 PARYLENE VARIANTS AND METHODS OF SYNTHESIS AND USE Specialty Coating Systems, Inc. (US) 2008-07-16 EP disclosed
WO-2007055822-A2 PARYLENE VARIANTS AND METHODS OF SYNTHESIS AND USE SPECIALTY COATING SYSTEMS, INC. (US) 2007-05-18 WO disclosed
US-20070099019-A1 Parylene variants and methods of synthesis and use SPECIALTY COATING SYSTEMS, INC. (US) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099019-A1 Parylene variants and methods of synthesis and use CDC73, PARN, PFAS ALDH1A1 3048/4885MAOB 862/4885TSHR 2174/4885
US-20090186998-A1 PARYLENE VARIANTS AND METHODS OF SYNTHESIS AND USE CDC73, PARN, PFAS ALDH1A1 2365/4885MAOB 733/4885TSHR 2311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.